Psoriatic arthritis screening by the dermatologist: development and first validation of the ‘<scp>PURE</scp>‐4 scale’

Audureau, Étienne; Roux, Fabienne; Danic, Dominique Lons; Bagot, Martine; Cantagrel, Alain; Dernis, Emmanuelle; Gouyette, N.; Hilliquin, P.; Jullien, D.; Lioté, Frédéric; Passeron, Thierry; Richard, M.‐A.; Claudepierre, Pascal

doi:10.1111/jdv.14861

Cited by 32 publications

(21 citation statements)

References 9 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…13 The overall performance of PURE-4 for diagnosing newly established PsA was good with sensitivity (85.7%) and specificity (83.6%), and an AUC of 0.88. 13 The Simple Psoriatic Arthritis Screening (SiPAS) questionnaire (5 questions), which is another tool that was developed to screen for PsA, was reported to have a sensitivity of 79% and a specificity of 87%. 14 SiPAT was designed as a short PsA screening tool (3 questions), which is similar to the 4-question PURE-4 and the 5-question SiPAS.…”

Section: Discussionmentioning

confidence: 86%

“…4,[6][7] The Psoriatic arthritis UnclutteRed screening Evaluation-4 (PURE-4) (4 questions) was recently developed for dermatologists to screen for PsA. 13 The overall performance of PURE-4 for diagnosing newly established PsA was good with sensitivity (85.7%) and specificity (83.6%), and an AUC of 0.88. 13 The Simple Psoriatic Arthritis Screening (SiPAS) questionnaire (5 questions), which is another tool that was developed to screen for PsA, was reported to have a sensitivity of 79% and a specificity of 87%.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Utility of the Siriraj Psoriatic Arthritis Screening Tool, the Thai Psoriasis Epidemiology Screening Tool, and the Early Arthritis for Psoriatic Patients Questionnaire to Screen for Psoriatic Arthritis in an Outpatient Dermatology Clinic Setting, and Identification of Factors Significantly Associated with Psoriatic Arthritis

Chularojanamontri

2019

Smj

View full text Add to dashboard Cite

Objective: To assess the clinical utility of the Psoriasis Epidemiology Screening Tool (PEST), the Early Arthritis for Psoriatic Patients (EARP) questionnaire, and the Siriraj Psoriatic Arthritis Screening Tool (SiPAT) as screening tools for psoriatic arthritis (PsA), and to identify factors significantly associated with PsA. Methods: This cross-sectional study included adult psoriasis patients who attended the outpatient clinic at Siriraj Hospital and had not been diagnosed with PsA during 1 March 2017 to 28 February 2018. Participants completed the EARP, PEST, and SiPAT, after which musculoskeletal history was taken, and examination and radiography were performed. Diagnosis of PsA was based on Classification Criteria for Psoriatic Arthritis. Receiver operator characteristic (ROC) curves, sensitivity, and specificity were used to determine assessment tool performance. Logistic regression analysis was used to identify factors associated with PsA. Results: Eighty-seven patients with a mean age of 45.90±14.75 years were enrolled. Twenty-six (29.88%) patients were diagnosed as PsA. According to ROC values, EARP had the best discriminative power (0.83) for distinguishing between psoriatic patients with and without PsA (SiPAT: 0.78, PEST: 0.77). SiPAT had the highest sensitivity (92.3%), followed by EARP (84.6%) and PEST (50.0%); whereas, PEST had the highest specificity (82.0%), followed by EARP (62.3%) and SiPAT (54.1%) for detecting PsA. Multivariate analysis revealed body surface area involvement >10% to be the only independent predictor of PsA (OR: 2.99, 95% CI: 1.09-8.21). Conclusion: SiPAT is an effective and simple to use tool for screening PsA in psoriasis patients. Body surface area involvement >10% is a significant predictor of PsA.

show abstract

Section: Discussionmentioning

confidence: 86%

Section: Discussionmentioning

confidence: 99%

Utility of the Siriraj Psoriatic Arthritis Screening Tool, the Thai Psoriasis Epidemiology Screening Tool, and the Early Arthritis for Psoriatic Patients Questionnaire to Screen for Psoriatic Arthritis in an Outpatient Dermatology Clinic Setting, and Identification of Factors Significantly Associated with Psoriatic Arthritis

Chularojanamontri

2019

Smj

View full text Add to dashboard Cite

show abstract

“…Recientemente se han elaborado otros dos nuevos cuestionarios: Simple Psoriatic Arthritis Screening (SiPAS) 37 y Psoriatic arthritis UnclutteRed screening Evaluation (PURE-4) 38 . El SiPAS es un cuestionario de 5 ítems que el propio paciente puede completar de manera rápida y que tiene una especificidad y una sensibilidad comparables a otros cuestionarios existentes (un 79% de sensibilidad y un 87% de especificidad) 37 .…”

Section: Resultsunclassified

“…El cuestionario PURE-4 se basa en los 4 dominios con mayor valor diagnóstico de APs en pacientes con psoriasis. Los resultados iniciales son prometedores (un 85,7% de sensibilidad y un 83,6% de especificidad) 38 y ha sido recientemente validado al castellano 39 .…”

Section: Resultsunclassified

El papel del dermatólogo en el diagnóstico precoz de la artritis psoriásica: recomendaciones de un grupo de expertos

Belinchón

Salgado‐Boquete

López‐Ferrer

et al. 2020

Actas Dermo-Sifiliográficas

View full text Add to dashboard Cite

Resumen La artritis psoriásica (APs) es una forma común de artritis inflamatoria que aparece hasta en el 40% de los pacientes con psoriasis. Dado que la afectación cutánea suele preceder a la afectación articular, los dermatólogos desempeñan un papel fundamental en la detección precoz de la APs. El diagnóstico precoz es importante para reducir el riesgo de daños estructurales irreversibles, limitar el deterioro de la función física y mejorar la calidad de vida de los pacientes. El presente documento ha sido elaborado por un grupo de especialistas (nueve dermatólogos y un reumatólogo) con el objetivo de proporcionar recomendaciones sencillas que ayuden a los dermatólogos en el cribado de la APs en pacientes con psoriasis. Los expertos elaboraron el presente documento ofreciendo unas recomendaciones consensuadas basadas en una revisión descriptiva de la evidencia científica disponible y en la experiencia adquirida en la práctica clínica diaria.

show abstract

“…In this issue, Audureau et al . described a simplified screening tool base on a critical analysis of screening tool available.…”

mentioning

confidence: 99%